HCLTech delivers strong Q3 FY25 with broad-based growth
HCL Tech
JANUARY 13, 2025
A Europe-based biopharma major and one of the worlds largest pharmaceutical and biomedical companies selected HCLTech to establish an innovative, enterprise-based digital hub leveraging its platform engineering and GenAI capabilities. Consolidated revenues as of 12 months ending December 2024 totaled $13.8 billion; EBIT margin at 19.5%
72 
Let's personalize your content